» Articles » PMID: 30226564

Upregulation of MiR-183-5p is Responsible for the Promotion of Apoptosis and Inhibition of the Epithelial-mesenchymal Transition, Proliferation, Invasion and Migration of Human Endometrial Cancer Cells by Downregulating Ezrin

Overview
Journal Int J Mol Med
Specialty Genetics
Date 2018 Sep 19
PMID 30226564
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Endometrial cancer is a life‑threatening malignancy that affects women all over the world, and it has an increasing incidence. MicroRNAs (miRNAs/miRs) have been reported to be involved in cellular activities in endometrial cancer. The present study aimed to examine the effects of miR‑183‑5p on the epithelial‑mesenchymal transition (EMT), proliferation, invasion, migration and apoptosis of human endometrial cancer cells by targeting Ezrin. Primary endometrial cancer tissues and adjacent normal tissues were obtained for the investigation. The protein expression of Ezrin in tissues was detected by immunohistochemistry. The expression level of miR‑183‑5p and the mRNA and protein expression levels of Ezrin and EMT‑associated genes were determined by reverse transcription‑quantitative polymerase chain reaction and western blot analyses. Endometrial cancer cells were treated with miR‑183‑5p inhibitors, small interfering RNA targeting Ezrin or miR‑183‑5p inhibitors. Cell proliferation, cell cycle, apoptosis, migration and invasion were then evaluated using an MTT assay, flow cytometry, scratch test and Transwell assay, respectively. Compared with normal adjacent tissues, the expression of miR‑183‑5p was decreased in endometrial cancer tissues, and the expression of Ezrin was significantly increased in endometrial cancer tissues. The protein expression of Ezrin was correlated with the severity and poor prognosis of endometrial cancer. Notably, the target prediction program and the luciferase reporter gene assay confirmed that miR‑183‑5p targeted and negatively regulated the expression of Ezrin. In vivo experiments revealed that the increased expression of miR‑183‑5p and decreased expression of Ezrin inhibited EMT, cell proliferation, migration and invasion, but promoted cell apoptosis in Ishikawa cells. These results suggested that the upregulated expression of miR‑183‑5p promoted apoptosis and suppressed the EMT, proliferation, invasion and migration of human endometrial cancer cells by downregulating Ezrin.

Citing Articles

Advances in MiRNAs Involved in Endometrial Carcinoma.

He Y, Liao K, Peng H, Zou X, Guo Z Comb Chem High Throughput Screen. 2024; 28(1):3-11.

PMID: 38504572 DOI: 10.2174/0113862073299444240308145725.


Discovery of novel microRNA mimic repressors of ribosome biogenesis.

Bryant C, McCool M, Rosado Gonzalez G, Abriola L, Surovtseva Y, Baserga S Nucleic Acids Res. 2024; 52(4):1988-2011.

PMID: 38197221 PMC: 10899765. DOI: 10.1093/nar/gkad1235.


MicroRNA-183 cluster: a promising biomarker and therapeutic target in gastrointestinal malignancies.

Zheng Y, Sukocheva O, Tse E, Neganova M, Aleksandrova Y, Zhao R Am J Cancer Res. 2024; 13(12):6147-6175.

PMID: 38187051 PMC: 10767355.


Identification of Endometrial Cancer-Specific microRNA Biomarkers in Endometrial Fluid.

Yang J, Barkley J, Bhattarai B, Firouzi K, Monk B, Coonrod D Int J Mol Sci. 2023; 24(10).

PMID: 37240034 PMC: 10218319. DOI: 10.3390/ijms24108683.


eIF2Bδ blocks the integrated stress response and maintains eIF2B activity and cancer metastasis by overexpression in breast cancer stem cells.

Gupta M, Walters B, Katsara O, Granados Blanco K, Geter P, Schneider R Proc Natl Acad Sci U S A. 2023; 120(15):e2207898120.

PMID: 37014850 PMC: 10104532. DOI: 10.1073/pnas.2207898120.


References
1.
Tang Y, Zhu L, Li Y, Yu J, Wang J, Zeng X . Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis. Biomed Res Int. 2017; 2017:5905384. PMC: 5376924. DOI: 10.1155/2017/5905384. View

2.
Tang J, Yu Z, Liu T, Lin Z, Wang Y, Yang L . Five miRNAs as novel diagnostic biomarker candidates for primary nasopharyngeal carcinoma. Asian Pac J Cancer Prev. 2014; 15(18):7575-81. DOI: 10.7314/apjcp.2014.15.18.7575. View

3.
Andersson G, Wennersten C, Gaber A, Boman K, Nodin B, Uhlen M . Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts. BMC Urol. 2014; 14:36. PMC: 4049499. DOI: 10.1186/1471-2490-14-36. View

4.
Ray M, Fleming G . Management of advanced-stage and recurrent endometrial cancer. Semin Oncol. 2009; 36(2):145-54. DOI: 10.1053/j.seminoncol.2008.12.006. View

5.
Zhu J, Feng Y, Ke Z, Yang Z, Zhou J, Huang X . Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin. Am J Pathol. 2012; 180(6):2440-51. DOI: 10.1016/j.ajpath.2012.02.023. View